News
Get the RSS
Category:
All
- Theranica, a Corundum’s portfolio, raised $45 million in its Series C financing round
- A Statement from Corundum System Biology Inc. in Advance of the International Human Microbiome Consortium Congress
- Initial Closing of Corundum’s Second Israeli VC Fund, and Start of Consulting Service for New Business Development
- Interview Article by Japan Patent Office and ASCII about IP Strategies of Israeli Startups